Syntagon Technical Director to Deliver Speech on Guaranteed CMC(s) Approval at CPhI Worldwide
Syntagon’s Technical Director, Dr. Anders Högdin, is set to deliver a presentation entitled "CMC(s) Approval Guaranteed" at the upcoming CPhI Worldwide exhibition in Frankfurt, Germany.
Syntagon is the only CRO that offers Guaranteed CMC(s) approval from regulatory authorities. Dr. Högdin’s speech will explore current regulatory requirements for drug substances in IMPD or IND submission, what the regulatory hot-spots are, and how Syntagon guarantees CMC(s) approval for its clients.
“As the only CRO able to guarantee our customers CMC(s) approval, we have a unique offering in the sector. All CPhI attendees are welcome to participate and find out how we help our clients obtain CMC(s) approval,” says Högdin.
Dr. Högdin’s presentation will be held on October the 25th at CPhI Worldwide’s ‘Speaker’s Corner’ at 1 PM.
With some 1,800 exhibitors and more than 25,000 participants, CPhI Worldwide is widely recognised as the pharma industry’s largest exhibition. This year’s event will be held in Frankfurt between October the 25th and 27th. First held in 1990, when just 16 exhibitors drew 250 visitors, CPhI has grown rapidly to become an event of key importance for the industry.
For further details on this press release, please contact John Cameron, Syntagon Director of Sales & Marketing Europe at john.cameron@syntagon.se.
Syntagon is a leading Scandinavia-based drug development partner. We develop compounds from lead optimisation to Phase III clinical trials using the latest technology and equipment combined with a solid quality system. For more about Syntagon, visit our website at www.syntagon.com, and follow us on Twitter.
Tags:
